Evidence map›Paper›PMID 39493836›Full record

ArticleLancet regional health. Americas2024

On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening.

Ovidiu Tatar, Ben Haward, Samara Perez, Patricia Zhu, Julia Brotherton, Kathleen Decker, Aisha K Lofters, Marie-Hélène Mayrand, Emily McBride, Gina Ogilvie and 6 more

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Mailing Vaginal or Urine Self-Sampling Kits versus Conventional Invitation Letters: A Randomized Trial to Assess the Effect on Cervical Cancer Screening Attendance.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Trial
  3. Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ovidiu TatarLady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.
Ben HawardLady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.
Samara PerezPsychosocial Oncology Program, Division of Supportive and Palliative Care, Cedars Cancer Centre, McGill University Health Centre, Montreal, QC, Canada.
Patricia ZhuLady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.
Julia BrothertonMelbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Kathleen DeckerDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Aisha K LoftersDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
Marie-Hélène MayrandResearch Center, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Emily McBrideInstitute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom.
Gina OgilvieBC Centre for Disease Control, Vancouver, BC, Canada.
Gilla K ShapiroDepartment of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Laurie W SmithBC Centre for Disease Control, Vancouver, BC, Canada.
Marc StebenHPV Global Action, Montreal, QC, Canada.
Jo WallerWolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Gregory D ZimetEmeritus School of Medicine, Indiana University, Indianapolis, IN, United States.
Zeev RosbergerLady Davis Institute for Medical Research, McGill University, Jewish General Hospital, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: HPV test-based primary cervical screening is replacing cytology in Canada. In other countries, women's unpreparedness and concerns hindered the transition and post-implementation screening uptake. We investigated psychosocial correlates of intentions of screening in eligible individuals to participate in HPV-based primary cervical screening. Methods: We conducted a nationwide web-based survey of individuals aged 21-70 years in 2022 and oversampled under-screened individuals. We used five Canadian-validated scales to measure HPV test-based screening knowledge, attitudes, and beliefs. Using the multistage Precaution Adoption Process Model, we assessed women's stage of intentions to participate in HPV testing and self-sampling. We estimated associations of psychosocial factors with intentions' stage using multinomial logistic regression. Findings: In both groups (adequately screened n = 1778; under-screened n = 1570), higher HPV knowledge was associated with intention for HPV testing and more personal barriers to the HPV test were associated with lower intentions to participate in HPV testing or use of self-sampling. In both groups, higher self-sampling concerns were associated with lower intentions for self-sampling and higher women's need for autonomy was associated with increased intentions for self-sampling. In the under-screened group, increased age was associated with lower intentions for HPV testing and self-sampling, while living in Canada for <10 years was associated with higher intentions. Interpretation: Our results could be used by policymakers and healthcare professionals to design communication strategies and ensure a smooth transition to HPV-based primary cervical screening, especially for under-screened individuals. Funding: Canadian Institutes of Health Research project grant 165905.

Indexed as

Attitudes and beliefsBehavioural sciencesCancer preventionCervical screeningHPV testingHuman papillomavirusObstetrics and gynecologyPublic healthReproductive healthScreening intentionsSelf-samplingWomen's health

Identifiers

PMID39493836
PMCPMC11530915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.